NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript
NovaBay Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.95 EPS, expectations were $-0.3.
Stay updated with breaking news from Call Transcript March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NovaBay Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.95 EPS, expectations were $-0.3.
GDS Holdings Limited misses on earnings expectations. Reported EPS is $-0.62 EPS, expectations were $-0.39.
Velo3D, Inc. misses on earnings expectations. Reported EPS is $-0.29 EPS, expectations were $-0.08.
TD SYNNEX Corporation misses on earnings expectations. Reported EPS is $1.95 EPS, expectations were $2.86.
Operator: Ladies and gentlemen. Thank you for standing by. Welcome to Acumen Pharmaceuticals Full Year 2023 Conference Call and Webcast. At this time, all participants are in a listen-only mode.